We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eyeing Oncology Market, MorphoSys Acquires Constellation Pharmaceuticals in Billion Dollar Deal
Eyeing Oncology Market, MorphoSys Acquires Constellation Pharmaceuticals in Billion Dollar Deal
In a move to expand its cancer drug offerings, German biotech MorphoSys has entered into an agreement to acquire Cambridge, Mass.-based Constellation Pharmaceuticals for $1.7 billion.